Treating Disorders Associated with IL-20 Receptor-Mediated Signaling Pathway by Blocking IL-20 Receptor Activity

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

本發明係有關於一種與IL-20受體所引導之訊息途徑有關之病症(如骨質疏鬆、腎臟衰竭或糖尿病性腎病變)的治療,其係使用抑制IL-20受體活性之藥劑,如經由結合IL-20R1而中和IL-20受體之抗體、以及抑制IL-20R1表現之反義核酸。
Original languageEnglish
Patent numberI448298
Publication statusPublished - 1800

Cite this